Thermo Fisher Scientific Inc.
TMO Stock News
Latest TMO news
Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
Business Wire · Wed, 23 Sep 2026 08:30:00 -0400
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the Gibco™ CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed media designed to support strong cell growth and protein production across CHO-K1 cell lines. Available in liquid and dry powder media (DPM) formats, the panel can offer flexible options for process development, scale-up, and manufacturing. The panel consists of multiple basal media and feed combinations designe.
Top 3 Health Care Stocks That May Keep You Up At Night This Month
Benzinga · Tue, 22 Sep 2026 08:57:01 -0400
As of Sept. 22, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Thermo Fisher Sees Stronger Demand, Calls 2026 an ‘Outstanding Year'
MarketBeat · Thu, 17 Sep 2026 06:02:25 -0400
Thermo Fisher Scientific NYSE: TMO Chairman and Chief Executive Officer Marc Casper said the company is seeing improving demand across several end markets and expects 2026 to be an “outstanding year,” supported by stronger customer activity and operational execution.
Thermo Fisher Scientific Inc. (TMO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha · Tue, 15 Sep 2026 11:31:46 -0400
Thermo Fisher Scientific Inc. (TMO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Here are the stocks to favor in the fourth quarter — and those you should avoid
Market Watch · Thu, 10 Sep 2026 18:02:00 -0400
Large caps tend to outperform small caps as year's end approaches.
Thermo Fisher, Wells Fargo, Nutrien And More On CNBC's ‘Final Trades'
Benzinga · Thu, 10 Sep 2026 07:37:06 -0400
On CNBC's “Halftime Report Final Trades,” Bryn Talkington, managing partner of Requisite Capital Management, picked Horizon Kinetics Inflation Beneficiaries ETF (NYSE:INFL).
Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in Focus
Zacks Investment Research · Tue, 08 Sep 2026 09:35:56 -0400
Zacks spotlights Oportun Financial, Uranium Royalty and Amgen, alongside standout gains from its key stock portfolios.
Market information is provided for research and visualization and is not investment advice.